Regression Modeling of ZAP-X Treatment Time

ZAP-X治疗时间的回归模型

阅读:1

Abstract

Accurate prediction of treatment time is critical in stereotactic radiosurgery (SRS) for optimizing patient scheduling and workflow efficiency. The ZAP-X system (ZAP Surgical Systems, Inc., San Carlos, CA), the newest cranial SRS platform, provides a built-in estimate of treatment time but often underestimates the actual treatment duration. This study aimed to develop a robust predictive model for ZAP-X treatment time, improving accuracy and reliability. Prospective data of 200 patients treated with ZAP-X SRS at Jersey Shore University Medical Center including timing metrics, treatment planning variables, and clinical factors were analyzed. Random Forest regression identified the most critical factors influencing treatment time. Subsequently, Ridge Regression was applied to develop a predictive model, with 10-fold cross-validation used for model tuning and validation. Random Forest analysis identified setup time and gantry time as the most influential variables affecting the treatment duration, followed by the number of beams, number of isocenters, dose, and target number. The Ridge Regression model demonstrated strong predictive performance (R² = 0.984, MAE = 1.94 minutes, RMSE = 2.49 minutes), significantly surpassing the ZAP-X system's internal estimates. The model's accuracy can be attributed to its ability to account for procedural variability, particularly in setup time. The Ridge Regression model provides a highly accurate and interpretable method for predicting ZAP-X treatment time, outperforming the system's internal calculations. This model has immediate clinical utility for improving patient scheduling and resource management in SRS. Future work should focus on validating the model across institutions and adapting it to evolving ZAP-X technology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。